Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
DOCS
#1292
Doximity, Inc. Class A Common Stock
21.4
0
USD
+1.04%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.04%
Monthly Change
-10.05%
6 month change
-58.04%
Year Change
-58.60%
Previous Close
21.1
8
Open
21.3
8
Low
21.2
6
High
21.5
7
Volume
1 617
Markets
US Stock Market
Healthcare
DOCS
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
2025
Total assets
991.36 M
1.14 B
1.08 B
1.26 B
1.12 B
Total liabilities
112.76 M
170.77 M
177.98 M
181.68 M
172.85 M
Total equity
878.59 M
966.12 M
901.4 M
1.08 B
950.84 M
Total liabilities & shareholders' equities
991.36 M
1.14 B
1.08 B
1.26 B
1.12 B
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
Doximity, Inc. Class A Common Stock
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration. The company is based in San Francisco.
News
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
Another Wall Street analyst slashes Doximity stock price outlook
DOCS vs. HIMS: Which Stock Is the Better Value Option?
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
HIMS Stock Dips 14.3% Since Q1 Earnings: Should You Still Hold or Sell?
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
Down 25.7% in 4 Weeks, Here's Why Doximity (DOCS) Looks Ripe for a Turnaround
S&P Futures Plunge as Inflation Fears Push Bond Yields Higher
Stocks Settle Higher on Strong Tech Earnings and Economic Resilience
Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down